BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 36924737)

  • 1. Molecular and metabolic mechanisms of bufalin against lung adenocarcinoma: New and comprehensive evidences from network pharmacology, metabolomics and molecular biology experiment.
    Shi S; Zhao S; Tian X; Liu F; Lu X; Zang H; Li F; Xiang L; Li L; Jiang S
    Comput Biol Med; 2023 May; 157():106777. PubMed ID: 36924737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A real-world study and network pharmacology analysis of EGFR-TKIs combined with ZLJT to delay drug resistance in advanced lung adenocarcinoma.
    Han X; Liang L; He C; Ren Q; Su J; Cao L; Zheng J
    BMC Complement Med Ther; 2023 Nov; 23(1):422. PubMed ID: 37990309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insight into Shenqi Jiangtang Granule on the improved insulin sensitivity by integrating in silico and in vivo approaches.
    Shi S; Sun M; Liu Y; Jiang J; Li F
    J Ethnopharmacol; 2022 Jan; 282():114672. PubMed ID: 34560213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring the mechanism of 6-Methoxydihydrosanguinarine in the treatment of lung adenocarcinoma based on network pharmacology, molecular docking and experimental investigation.
    Liu X; Ren Y; Qin S; Yang Z
    BMC Complement Med Ther; 2024 May; 24(1):202. PubMed ID: 38783288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determining the mechanism of action of the Qishan formula against lung adenocarcinoma by integration of network pharmacology, molecular docking, and proteomics.
    Geng X; Chi W; Lin X; Niu Z; Jiang Q; Sui Y; Jiang J
    Medicine (Baltimore); 2023 Mar; 102(13):e33384. PubMed ID: 37000102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring the Mechanism of Zilongjin in Treating Lung Adenocarcinoma Based on Network Pharmacology Combined with Experimental Verification.
    Zhang K; Chen X
    Crit Rev Immunol; 2024; 44(5):27-40. PubMed ID: 38618726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrating Network Pharmacology, Molecular Docking, and Experimental Validation to Investigate the Mechanism of (-)-Guaiol Against Lung Adenocarcinoma.
    Zeng Y; Pan Y; Zhang B; Luo Y; Tian J; Wang Y; Ju X; Wu J; Li Y
    Med Sci Monit; 2022 Jul; 28():e937131. PubMed ID: 35871777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A network pharmacology approach and experimental validation to investigate the anticancer mechanism and potential active targets of ethanol extract of Wei-Tong-Xin against colorectal cancer through induction of apoptosis via PI3K/AKT signaling pathway.
    Lin F; Zhang G; Yang X; Wang M; Wang R; Wan M; Wang J; Wu B; Yan T; Jia Y
    J Ethnopharmacol; 2023 Mar; 303():115933. PubMed ID: 36403742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of "Hedyotis Diffusae Herba-Smilacis Glabrae Rhizoma" in treatment of lung adenocarcinoma based on network pharmacology].
    Li JL; Hou W
    Zhongguo Zhong Yao Za Zhi; 2021 Dec; 46(23):6261-6270. PubMed ID: 34951253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of Key Ingredient of Astragalus membranaceus on Lung Adenocarcinoma via PI3K/AKT Signaling Clarified by Utilizing Network Pharmacology Approach and Experimental Validation.
    Wang YC; Hui JR; Xiao G; Ma QL
    Chin J Integr Med; 2023 Mar; 29(3):244-252. PubMed ID: 36044117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma.
    Zhao XY; Yang YY; Feng JL; Feng CL
    J Vis Exp; 2023 Mar; (193):. PubMed ID: 36939253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Network Pharmacology and Experimental Verification to Explore the Potential Mechanism of Yin-Huo-Tang for Lung Adenocarcinoma Recurrence.
    Liu D; Lin S; Li Y; Zhou T; Hu K; Li Q
    Drug Des Devel Ther; 2022; 16():375-395. PubMed ID: 35210754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The therapeutic mechanism of Yuye decoction on type 2 diabetes mellitus based on network pharmacology and experimental verification.
    Guo F; Yao L; Zhang W; Chen P; Hao R; Huang X; Jiang J; Wu S
    J Ethnopharmacol; 2023 May; 308():116222. PubMed ID: 36828194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploration of the Effect and Potential Mechanism of Echinacoside Against Endometrial Cancer Based on Network Pharmacology and in vitro Experimental Verification.
    Shu W; Wang Z; Zhao R; Shi R; Zhang J; Zhang W; Wang H
    Drug Des Devel Ther; 2022; 16():1847-1863. PubMed ID: 35734366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Network Pharmacology and Bioinformatics Analysis Identifies Potential Therapeutic Targets of Paxlovid Against LUAD/COVID-19.
    Zhang W; Yang Z; Zhou F; Wei Y; Ma X
    Front Endocrinol (Lausanne); 2022; 13():935906. PubMed ID: 36157452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrating Network Pharmacology and Experimental Verification to Explore the Pharmacological Mechanisms of Aloin Against Gastric Cancer.
    Gao J; Yang S; Xie G; Pan J; Zhu F
    Drug Des Devel Ther; 2022; 16():1947-1961. PubMed ID: 35757520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deciphering the pharmacological mechanisms of Scutellaria baicalensis Georgi on oral leukoplakia by combining network pharmacology, molecular docking and experimental evaluations.
    Hou F; Yu Z; Cheng Y; Liu Y; Liang S; Zhang F
    Phytomedicine; 2022 Aug; 103():154195. PubMed ID: 35667260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unveiling the potential mechanisms of Amomi fructus against gastric ulcers via integrating network pharmacology and in vivo experiments.
    Lv Y; Li J; Li Y; Su J; Ding X; Yuan Y; Liu S; Mou Y; Li G; Zhang L
    J Ethnopharmacol; 2024 Jan; 319(Pt 2):117179. PubMed ID: 37777029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integration of Network Pharmacology and Molecular Docking Technology Reveals the Mechanism of the Therapeutic Effect of Xixin Decoction on Alzheimer's Disease.
    Zhang Z; Xu J; Ma S; Lin N; Hou M; Wei M; Li T; Shi J
    Comb Chem High Throughput Screen; 2022; 25(10):1785-1804. PubMed ID: 35616676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Network Pharmacology and Molecular Docking Analysis on Molecular Targets and Mechanisms of Fei Jin Sheng Formula in the Treatment of Lung Cancer.
    Zhang YC; Gao WC; Chen WJ; Pang DX; Mo DY; Yang M
    Curr Pharm Des; 2023; 29(14):1121-1134. PubMed ID: 37138492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.